Home LiteratureArticle Details
PMID: 15271942 Published · ppublish English Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Murine model of pulmonary anthrax: kinetics of dissemination, histopathology, and mouse strain susceptibility.

Infection and immunity ·Vol. 72 ·No. 8 ·2004-08-00 ·Pages 4801-9

Lyons CR, Lovchik J, Hutt J, Lipscomb MF, Wang E, Heninger S, Berliba L, Garrison K

Abstract

Bioweapons are most often designed for delivery to the lung, although this route is not the usual portal of entry for many of the pathogens in the natural environment. Vaccines and therapeutics that are efficacious for natural routes of infection may not be effective against the pulmonary route. Pulmonary models are needed to investigate the importance of specific bacterial genes in virulence, to identify components of the host immune system that are important in providing innate and acquired protection, and for testing diagnostic and therapeutic strategies. This report describes the characteristics of host and Bacillus anthracis interactions in a murine pulmonary-infection model. The infective dose varied depending on the route and method of inoculation. The germination process in the lung began within 1 h of inoculation into the lung, although growth within the lung was limited. B. anthracis was found in the lung-associated lymph nodes approximately 5 h after infection. Minimal pneumonitis was associated with the lung infection, but significant systemic pathology was noted after dissemination. Infected mice typically succumbed to infection approximately 3 to 4 days after inoculation. The 50% lethal doses differed among inbred strains of mice, but within a given mouse strain, neither the age nor the sex of the mice influenced susceptibility to B. anthracis.

MeSH Terms
Administration, Intranasal Animals Animals, Inbred Strains Anthrax/microbiology,pathology,physiopathology Bacillus anthracis/isolation & purification,pathogenicity,physiology Disease Models, Animal Disease Susceptibility Female Lung/pathology Male Mice Mice, Inbred BALB C Pneumonia, Bacterial/microbiology,pathology,physiopathology Species Specificity Spleen/pathology Spores, Bacterial/pathogenicity
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Lyons C Rick
Department of Internal Medicine, University of New Mexico Health Science Center, Albuquerque, 87131, USA. [email protected]
Lovchik Julie
Hutt Julie
Lipscomb Mary F
Wang Eugenia
Heninger Sara
Berliba Lucy
Garrison Kristin
References (38)
38 references, click to expand
  1. Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice.
    J Clin Invest. 2003 Sep;112(5):670-82 PMID: 12952916
  2. Anthrax spores make an essential contribution to vaccine efficacy.
    Infect Immun. 2002 Feb;70(2):661-4 PMID: 11796596
  3. Inhalational Anthrax.
    Curr Infect Dis Rep. 2002 Jun;4(3):238-243 PMID: 12015917
  4. Bacillus anthracis protective antigen, expressed in Salmonella typhimurium SL 3261, affords protection against anthrax spore challenge.
    Vaccine. 1994 Nov;12(15):1395-401 PMID: 7887017
  5. Anthrax toxin.
    Crit Rev Microbiol. 2001;27(3):167-200 PMID: 11596878
  6. The Sverdlovsk anthrax outbreak of 1979.
    Science. 1994 Nov 18;266(5188):1202-8 PMID: 7973702
  7. Epidemiologic investigations of bioterrorism-related anthrax, New Jersey, 2001.
    Emerg Infect Dis. 2002 Oct;8(10):1048-55 PMID: 12396914
  8. Germination of Bacillus anthracis spores within alveolar macrophages.
    Mol Microbiol. 1999 Jan;31(1):9-17 PMID: 9987105
  9. Germination of Bacillus cereus spores in response to L-alanine and to inosine: the roles of gerL and gerQ operons.
    Microbiology. 2002 Jul;148(Pt 7):2089-95 PMID: 12101297
  10. Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979.
    Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2291-4 PMID: 8460135
  11. Molecular pathogenesis of Bacillus anthracis infection.
    Microbes Infect. 1999 Feb;1(2):131-9 PMID: 10594977
  12. Anthrax.
    Annu Rev Microbiol. 2001;55:647-71 PMID: 11544370
  13. Biological warfare. A historical perspective.
    JAMA. 1997 Aug 6;278(5):412-7 PMID: 9244333
  14. Passive transfer of protection against Bacillus anthracis infection in a murine model.
    Vaccine. 2001 Aug 14;19(31):4409-16 PMID: 11483266
  15. Differences in susceptibility of inbred mice to Bacillus anthracis.
    Infect Immun. 1986 Mar;51(3):795-800 PMID: 3081444
  16. Amino acid- and purine ribonucleoside-induced germination of Bacillus anthracis DeltaSterne endospores: gerS mediates responses to aromatic ring structures.
    J Bacteriol. 2002 Mar;184(5):1296-303 PMID: 11844758
  17. Anthrax as a biological weapon, 2002: updated recommendations for management.
    JAMA. 2002 May 1;287(17):2236-52 PMID: 11980524
  18. The immune system in the elderly: II. Specific cellular immunity.
    Immunol Res. 1999;20(2):109-15 PMID: 10580636
  19. Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis.
    Microb Pathog. 1988 Jan;4(1):53-69 PMID: 3143893
  20. Pathology of experimental inhalation anthrax in the rhesus monkey.
    Lab Invest. 1995 Nov;73(5):691-702 PMID: 7474943
  21. Bacillus anthracis.
    J Clin Pathol. 2003 Mar;56(3):182-7 PMID: 12610093
  22. Bacillus anthracis genetics and virulence gene regulation.
    Curr Top Microbiol Immunol. 2002;271:143-64 PMID: 12224521
  23. Polymorphonuclear functions and aging in humans.
    J Am Geriatr Soc. 1981 Sep;29(9):391-7 PMID: 7264130
  24. Spore germination.
    Cell Mol Life Sci. 2002 Mar;59(3):403-9 PMID: 11964118
  25. Woolsorters' disease. An experimental model.
    Arch Pathol. 1971 Dec;92(6):418-26 PMID: 5001047
  26. Bacterial spore germination and protein mobility.
    Trends Microbiol. 2003 Oct;11(10):452-4 PMID: 14557026
  27. Aging and immunity to tuberculosis: increased susceptibility of old mice reflects a decreased capacity to generate mediator T lymphocytes.
    J Immunol. 1987 Jun 15;138(12):4414-8 PMID: 3495592
  28. Respiratory pathogenicity of Bacillus anthracis spores; genetic variation in respiratory pathogenicity and invasiveness of colonial variants of B. anthracis.
    J Infect Dis. 1946 Nov-Dec;79(3):247-53 PMID: 20278393
  29. Pathology and pathogenesis of bioterrorism-related inhalational anthrax.
    Am J Pathol. 2003 Aug;163(2):701-9 PMID: 12875989
  30. Intrapulmonary distribution of deposited particles.
    J Aerosol Med. 1999 Winter;12(4):275-84 PMID: 10724642
  31. Protective immunity induced by Bacillus anthracis toxin-deficient strains.
    Infect Immun. 1995 Apr;63(4):1369-72 PMID: 7890396
  32. Quantitative pathology of inhalational anthrax I: quantitative microscopic findings.
    Mod Pathol. 2001 May;14(5):482-95 PMID: 11353060
  33. Immunization against anthrax with aromatic compound-dependent (Aro-) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen.
    Infect Immun. 1990 Feb;58(2):303-8 PMID: 2105269
  34. Bacillus anthracis infection in irradiated mice: susceptibility, protection, and therapy.
    Mil Med. 2002 Feb;167(2 Suppl):103-4 PMID: 11873486
  35. Anthrax toxins and the host: a story of intimacy.
    Cell Microbiol. 2003 Jan;5(1):15-23 PMID: 12542467
  36. The stability of messenger ribonucleic acid during sporulation in Bacillus subtilis.
    J Biol Chem. 1971 May 25;246(10):3189-95 PMID: 4995746
  37. Pathology of inhalation anthrax in cynomolgus monkeys (Macaca fascicularis).
    Lab Invest. 2003 Aug;83(8):1201-9 PMID: 12920249
  38. Early Bacillus anthracis-macrophage interactions: intracellular survival survival and escape.
    Cell Microbiol. 2000 Dec;2(6):453-63 PMID: 11207600
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
2004-08-00
Pages
4801-9
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC470666
Subset
IM
Grants
NIAID NIH HHS · U54 AI057156 · United States
NHLBI NIH HHS · P50 HL 56384 · United States
NHLBI NIH HHS · P50 HL056384 · United States
NIAID NIH HHS · 1U54 AI057156-01 · United States
NHLBI NIH HHS · R01 HL64548 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]